Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07547202

Effect of Non-Surgical Periodontal Therapy on Salivary Biomarkers in Smokers and Non-Smokers With Periodontitis

Led by Al-Mustansiriyah University · Updated on 2026-04-23

44

Participants Needed

2

Research Sites

39 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study evaluates the effect of non-surgical periodontal therapy on salivary biomarkers (Dkk-1, Sclerostin, and PLAP-1) and clinical periodontal parameters in patients with periodontitis. Periodontitis is a chronic inflammatory disease that destroys tooth-supporting tissues. Smoking is a significant risk factor that worsens periodontal destruction and reduces the effectiveness of standard therapies. * The trial is a non-randomized comparative clinical study. * It includes 44 adult patients diagnosed with Stage II and III periodontitis. * The participants are divided into two equal groups: 22 current smokers and 22 non-smokers. * Participants will undergo a baseline examination, followed by standardized non-surgical periodontal therapy consisting of scaling and root planing. * A follow-up visit will be conducted six weeks post-therapy to repeat clinical measurements and saliva collection. * The primary objective is to evaluate changes in salivary biomarker levels and clinical parameters (Plaque Index, Gingival Index, bleeding on probing, Probing Pocket Depth, Clinical Attachment Level) after treatment.

CONDITIONS

Official Title

Effect of Non-Surgical Periodontal Therapy on Salivary Biomarkers in Smokers and Non-Smokers With Periodontitis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Systemically healthy.
  • Diagnosed with Stage II and III periodontitis.
  • Presence of ≥ 20 teeth (excluding third molars).
  • Current smoker OR non-smoker
Not Eligible

You will not qualify if you...

  • Presence of systemic diseases affecting the periodontium.
  • Use of medications affecting inflammation.
  • Received periodontal therapy in the past 6 months.
  • Received antibiotic therapy in the last 3 months.
  • Alcohol use.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Al-Sadr Specialized Dental Center

Baghdad, Baghdad Governorate, Iraq, 10001

Actively Recruiting

2

Sadr Specialized Dental Center

Baghdad, Baghdad Governorate, Iraq

Actively Recruiting

Loading map...

Research Team

H

Hussein Abdul-Rassul Hatiem, B.D.S., M.Sc. Student

CONTACT

G

Ghasaq Asim Abdulwahab, B.D.S., M.Sc., Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Effect of Non-Surgical Periodontal Therapy on Salivary Biomarkers in Smokers and Non-Smokers With Periodontitis | DecenTrialz